Related Experiment Video
Updated: May 27, 2026

Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction
Published on: December 3, 2017
Molecular diagnostics in periprosthetic joint infection
Javad Parvizi1, Lesley Walinchus, Bahar Adeli
1The Rothman Institute of Orthopaedics, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA. research@rothmaninstitute.com
Abstract:
Periprosthetic joint infection (PJI) is a significant and costly challenge to the orthopedic community. The lack of a gold standard for diagnosis remains the biggest obstacle in the detection and subsequent treatment of PJI. Molecular markers in the serum and joint fluid aspirate hold immense promise to enhance the development of a firm diagnostic criterion. The primary goal is one marker with high sensitivity and specificity. Here, we review our current research efforts in the field of molecular markers: C-reactive protein, erythrocyte sedimentation rate, white blood cells, and leukocyte esterase. Each marker has been studied to determine its sensitivity, specificity, and positive and negative predictive values in diagnosing PJI.
Insights
Diagnosing periprosthetic joint infection (PJI) is challenging due to the lack of a gold standard. This review examines molecular markers like C-reactive protein to improve PJI detection accuracy.
Area of Science:
- Orthopedics
- Infectious Diseases
- Biomarkers
Background:
- Periprosthetic joint infection (PJI) presents a significant clinical and economic burden.
- Current diagnostic methods for PJI lack a definitive gold standard, hindering effective treatment.
- Molecular markers in biological fluids offer potential for improved PJI diagnosis.
Purpose of the Study:
- To review current research on molecular markers for diagnosing PJI.
- To evaluate the sensitivity, specificity, and predictive values of key markers.
- To identify a potential single marker with high diagnostic accuracy for PJI.
Main Methods:
- Literature review of studies investigating molecular markers for PJI.
- Analysis of diagnostic performance metrics including sensitivity and specificity.
- Evaluation of C-reactive protein, erythrocyte sedimentation rate, white blood cells, and leukocyte esterase.
Main Results:
- Several molecular markers show promise in aiding PJI diagnosis.
- Each marker possesses varying degrees of sensitivity and specificity.
- No single marker currently meets the criteria for a definitive gold standard.
Conclusions:
- Molecular markers are valuable adjuncts in diagnosing PJI.
- Further research is needed to establish a reliable diagnostic criterion.
- The development of a highly sensitive and specific marker is crucial for PJI management.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Automated Microbial Diagnostics
Modern Molecular Taxonomy
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Endocarditis I: Introduction

